Original Research

Published on 25 Nov 2022

The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition

in Pharmacoepidemiology

GYeon Oh
Daniela C. Moga
David W. Fardo
Erin L. Abner

Frontiers in Pharmacology

doi 10.3389/fphar.2022.910719

39,349 views
5 citations

Correction

Published on 24 Nov 2022

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs

in Pharmacoepidemiology

Martijn J. Schuemie
Faaizah Arshad
Nicole Pratt
Fredrik Nyberg
Thamir M Alshammari
George Hripcsak
Patrick Ryan
Daniel Prieto-Alhambra
Lana Y. H. Lai
Xintong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1088973

907 views

Original Research

Published on 24 Nov 2022

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

in Pharmacoepidemiology

Sophie H. Bots
Judit Riera-Arnau
Svetlana V. Belitser
Davide Messina
Maria Aragón
Ema Alsina
Ian J. Douglas
Carlos E. Durán
Patricia García-Poza
Rosa Gini

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1038043

7,896 views
19 citations

Original Research

Published on 24 Nov 2022

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

in Pharmacoepidemiology

Ya-Hui Yu
In-Sun Oh
Han Eol Jeong
Robert W. Platt
Antonios Douros
Ju-Young Shin
Kristian B. Filion

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1034636

1,862 views
1 citation

Original Research

Published on 24 Nov 2022

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

in Pharmacoepidemiology

J. Barceló-Vidal
D. Echeverría-Esnal
N. Carballo
M. De Antonio-Cuscó
X. Fernández-Sala
M. E. Navarrete-Rouco
E. Colominas-González
S. Luque
M. Fuster-Esteva
L. Domingo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.993158

2,997 views
2 citations

Original Research

Published on 24 Nov 2022

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS

in Pharmacoepidemiology

Zhen Feng
Xiaoye Li
Wai Kei Tong
Qingfeng He
Xiao Zhu
Xiaoqiang Xiang
Zhijia Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.894685

9,143 views
17 citations

Systematic Review

Published on 24 Nov 2022

The association between statin use and osteoarthritis-related outcomes: An updated systematic review and meta-analysis

in Pharmacoepidemiology

Zhan Zhang
Chunbo Deng
Xun Ma
Qijun Wu
Fenghua Zhou
Xueyong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1003370

10,375 views
7 citations

Original Research

Published on 17 Nov 2022

Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey

in Pharmacoepidemiology

Ohoud S. Almalki
Amany S. Khalifa
Ozouf F. Alhemeidi
Ashraf A. Ewis
Abeer M. Shady
Sayed F. Abdelwahab

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1006333

3,736 views
4 citations

Original Research

Published on 16 Nov 2022

Real-world patterns of opioid therapy initiation in Spain, 2012–2018: A population-based, retrospective cohort study with 957,080 patients and 1,509,488 initiations

in Pharmacoepidemiology

Isabel Hurtado
Celia Robles
Salvador Peiró
Aníbal García-Sempere
Fran Llopis-Cardona
Francisco Sánchez-Sáez
Clara Rodríguez-Bernal
Gabriel Sanfélix-Gimeno

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1025340

2,664 views
6 citations

Original Research

Published on 10 Nov 2022

Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank

in Pharmacoepidemiology

Xing-Yu Zhang
Qiang-Sheng He
Zhong Jing
Juan-Xia He
Jin-Qiu Yuan
Xiao-Yu Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2022.949699

4,326 views
12 citations

Original Research

Published on 10 Nov 2022

Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System

in Pharmacoepidemiology

Takamasa Sakai
Chiyo Mori
Fumiko Ohtsu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063625

3,469 views
6 citations

Original Research

Published on 10 Nov 2022

In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design

in Pharmacoepidemiology

C. A. M. Hartwig
R. Robiyanto
S. de Vos
J. H. J. Bos
E. P. van Puijenbroek
E. Hak
C. C. M. Schuiling-Veninga

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1000018

2,779 views
2 citations

Clinical Trial

Published on 10 Nov 2022

A machine-learning guided method for predicting add-on and switch in secondary data sources: A case study on anti-seizure medications in Danish registries

in Pharmacoepidemiology

Peter Suhr Breitenstein
Israa Mahmoud
Fahed Al-Azzawi
Saeed Shakibfar
Maurizio Sessa

Frontiers in Pharmacology

doi 10.3389/fphar.2022.954393

2,249 views
4 citations

Correction

Published on 09 Nov 2022

Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system

in Pharmacoepidemiology

Haoning Guo
Bin Wang
Shuying Yuan
Silin Wu
Jing Liu
Miaoquan He
Jisheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1075966

1,422 views
3 citations

Original Research

Published on 07 Nov 2022

Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS

in Pharmacoepidemiology

Ming-Ming Yan
Hui Zhao
Zi-Ran Li
Jun-Wei Chow
Qian Zhang
Yu-Peng Qi
Shu-Shan Wu
Ming-Kang Zhong
Xiao-Yan Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.921760

5,854 views
7 citations

Original Research

Published on 25 Oct 2022

GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS

in Pharmacoepidemiology

Zheng Yang
Yuhuan Lv
Meng Yu
Mei Mei
Linyu Xiang
Subei Zhao
Rong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.925377

47,298 views
50 citations

Navigation group

Articles

The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs

Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS

The association between statin use and osteoarthritis-related outcomes: An updated systematic review and meta-analysis

Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey

Real-world patterns of opioid therapy initiation in Spain, 2012–2018: A population-based, retrospective cohort study with 957,080 patients and 1,509,488 initiations

Effect of proton pump inhibitors on the risk of chronic kidney disease: A propensity score-based overlap weight analysis using the United Kingdom Biobank

Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System

In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design

A machine-learning guided method for predicting add-on and switch in secondary data sources: A case study on anti-seizure medications in Danish registries

Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system

Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS

GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS